Full Name
Sui Yung Chan
Variants
Yung, C.S.
Chan, S.-Y.
Chan, S.Y
Sui, Y.C.
Chan, S.Y.
Chan, Sui-Yung
Yung Chan, S.
 
Main Affiliation
 
Faculty
 
Email
phacsy@nus.edu.sg
 

Publications

Refined By:
Author:  Zhou, S.-F.

Results 1-20 of 23 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
1Jun-2006A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhizaZhang, J.; Huang, M.; Guan, S.; Bi, H.-C.; Pan, Y.; Duan, W.; Sui, Y.C. ; Chen, X.; Hong, Y.-H. ; Bian, J.-S.; Yang, H.-Y.; Zhou, S. 
21-Sep-2005Determination of thalidomide by high performance liquid chromatography: Plasma pharmacokinetic studies in the ratYang, X.; Hu, Z.; Sui, Y.C. ; Ho, P.C. ; Chan, E. ; Duan, W.; Boon, C.G.; Zhou, S. 
32005Herb-drug interactions: A literature reviewHu, Z.; Yang, X.; Ho, P.C.L. ; Sui, Y.C. ; Heng, P.W.S. ; Chan, E. ; Duan, W.; Hwee, L.K. ; Zhou, S. 
4Oct-2005Insights into oxazaphosphorine resistance and possible approaches to its circumventionZhang, J.; Tian, Q. ; Chan, S.Y. ; Duan, W.; Zhou, S. 
52005Insights into oxazaphosphorine resistance and possible approaches to its circumventionZhang, J.; Tian, Q.; Chan, S.Y. ; Zhou, S. ; Duan, W. 
62005Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsZhou, S. ; Chan, S.Y. ; Goh, B.C.; Chan, E. ; Duan, W.; Huang, M.; McLeod, H.L.
72005Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsZhou, S. ; Chan, S.Y. ; Chan, E.; Goh, B.C. ; Duan, W. ; Huang, M.; McLeod, H.L.
8Jul-2005Metabolism and transport of oxazaphosphorines and the clinical implicationsZhang, J.; Tian, Q. ; Sui, Y.C. ; Shu, C.L. ; Zhou, S. ; Duan, W.; Zhu, Y.-Z.
9Mar-2006Monitoring drug-protein interactionYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Zhou, S.-F. 
10Mar-2006Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancerChen, X.; Hu, Z.-P.; Yang, X.-X.; Huang, M.; Gao, Y.; Tang, W.; Chan, S.Y. ; Dai, X.; Ye, J.; Ho, P.C.-L. ; Duan, W.; Yang, H.-Y.; Zhu, Y.-Z.; Zhou, S.-F. 
112006Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancerChen, X.; Hu, Z.-P.; Yang, X.-X.; Chan, S.Y. ; Ho, P.C.-L.; Zhou, S.-F. ; Huang, M.; Gao, Y.; Tang, W.; Dai, X.; Ye, J.; Duan, W. ; Yang, H.-Y.; Zhu, Y.-Z. 
122005Novel agents that potentially inhibit irinotecan-induced diarrheaYang, X.; Hu, Z.; Chan, S.Y. ; Chan, E. ; Goh, B.C.; Duan, W.; Zhou, S. 
132005Novel agents that potentially inhibit irinotecan-induced diarrheaYang, X.; Hu, Z.; Chan, S.Y. ; Chan, E.; Zhou, S. ; Goh, B.C. ; Duan, W. 
14May-2006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Duan, W.; Ho, P.C.-L. ; Boelsterli, U.A.; Ng, K.-Y. ; Chan, E. ; Bian, J.-S.; Chen, Y.-Z. ; Huang, M.; Zhou, S.-F. 
152006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Ho, P.C.-L. ; Boelsterli, U.A. ; Ng, K.-Y. ; Chan, E.; Chen, Y.-Z. ; Zhou, S.-F. ; Duan, W. ; Bian, J.-S. ; Huang, M.
162006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Ho, P.C.-L. ; Boelsterli, U.A. ; Ng, K.-Y. ; Chan, E.; Chen, Y.-Z. ; Zhou, S.-F. ; Duan, W. ; Bian, J.-S. ; Huang, M.
17May-2006Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in ChineseZhong, S.-L.; Zhou, S.-F. ; Chen, X.; Chan, S.Y. ; Chan, E. ; Ng, K.-Y. ; Duan, W.; Huang, M.
182006Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in ChineseZhong, S.-L.; Huang, M.; Zhou, S.-F. ; Chan, S.Y. ; Chan, E.; Ng, K.-Y. ; Chen, X.; Duan, W. 
1925-Jul-2005Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: Application to plasma pharmacokinetic studies in the ratYang, X.; Hu, Z.; Sui, Y.C. ; Goh, B.C.; Duan, W.; Chan, E. ; Zhou, S. 
2015-Oct-2006St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosisHu, Z.-P.; Yang, X.-X.; Chan, S.Y. ; Xu, A.-L.; Duan, W.; Zhu, Y.-Z.; Sheu, F.-S. ; Boelsterli, U.A.; Chan, E. ; Zhang, Q.; Wang, J.-C.; Ee, P.L.R. ; Koh, H.L. ; Huang, M.; Zhou, S.-F.